![VERNAL BIOSCIENCES](https://www.impactnews-wire.com/wp-content/uploads/2024/01/Screen-Shot-2022-06-01-at-2.50.39-PM-2.png)
Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation
COLCHESTER, Vt.–(BUSINESS WIRE)–Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of Sven Lee, Chief Commercial Officer, and Richard P. Hamel, Chief Financial Officer to its leadership team. Both distinguished leaders will strengthen Vernal’s position as a premier mRNA and LNP Contract Development and Manufacturing Organization (CDMO) while using their deep experience to deliver … Continue reading Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation